NDC 63323-715 – Fulvestrant

Fulvestrant 50 mg/mL · Injection, Solution · Intramuscular

Human Prescription Drug

Product NDC63323-715

Product details

Brand name
Fulvestrant
Generic name
Fulvestrant
Labeler
Fresenius Kabi USA, LLC
Dosage form
Injection, Solution
Route
Intramuscular
Marketing category
NDA · NDA210326
Marketed since
May 20, 2019
Listing expires
December 31, 2026
Pharmacologic class
Estrogen Receptor Antagonist

Active ingredients

Uses, dosage, side effects and warnings for Fulvestrant →

Package NDC codes (1)

Package NDCDescriptionSince
63323-715-052 SYRINGE, GLASS in 1 CARTON (63323-715-05) / 5 mL in 1 SYRINGE, GLASS (63323-715-01)May 20, 2019

Other Fulvestrant products